Canada - English - Health Canada

mylan pharmaceuticals ulc - pantoprazole (pantoprazole sodium sesquihydrate) - powder for solution - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

Canada - English - Health Canada

accord healthcare inc - pantoprazole (pantoprazole sodium sesquihydrate) - powder for solution - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - pantoprazole sodium sesquihydrate - tablets gastro-resistant - 20 milligram - pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - pantoprazole sodium sesquihydrate - tablets gastro-resistant - 40 milligram - pantoprazole

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - pantoprazole sodium sesquihydrate, quantity: 22.7 mg (equivalent: pantoprazole, qty 20 mg) - tablet, enteric coated - excipient ingredients: mannitol; sodium carbonate; sodium starch glycollate; crospovidone; colloidal anhydrous silica; calcium stearate; hypromellose; macrogol 6000; sodium hydroxide; polysorbate 80; purified water; methacrylic acid copolymer; sodium lauryl sulfate; titanium dioxide; purified talc; iron oxide yellow; xanthan gum; polyvinyl alcohol; lecithin - 1. for symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion: i) duodenal ulcer; ii) gastric ulcer; iii) gastro-oesophageal reflux disease (gord): symptomatic gord. the treatment of heartburn and other symptoms associated with gord; reflux oesophagitis; iv) gastrointestinal lesions refractory h2 blockers; v) zollinger-ellison syndrome. patients whose gastric or duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. 2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. 3. prevention of gastroduodenal lesions and dyspeptic symptoms associated with non-selective non-steroidal anti-inflammatory drugs (nsaids) in increased risk patients with a need for continuous non-selective nsaid treatment.

United States - English - NLM (National Library of Medicine)

proficient rx lp - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 20 mg - pantoprazole sodium delayed-release tablets, usp are indicated for: pantoprazole sodium delayed-release tablets are indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. for those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole sodium delayed-release may be considered. safety of treatment beyond 8 weeks in pediatric patients has not been established. pantoprazole sodium delayed-release tablets are indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with gerd. controlled studies did not extend beyond 12 months. pantoprazole sodium delayed-release tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including zollinger-ellison syndrome. pantoprazole sodium delayed-release tablets are contraind

Ireland - English - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; pantoprazole

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

takeda uk ltd - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20mg